BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6704957)

  • 1. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines.
    Washtien WL
    Cancer Res; 1984 Mar; 44(3):909-14. PubMed ID: 6318987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
    Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
    Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose 5-fluorouracil with delayed uridine "rescue" in mice.
    Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW
    Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC; Stolfi RL; Martin DS; Spiegelman S
    Cancer Res; 1984 May; 44(5):1847-51. PubMed ID: 6713387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
    Sommadossi JP; Carlisle R; Zhou Z
    Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.
    Stolfi RL; Martin DS; Sawyer RC; Spiegelman S
    Cancer Res; 1983 Feb; 43(2):561-6. PubMed ID: 6184150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
    Parker WB; Kennedy KA; Klubes P
    Cancer Res; 1987 Feb; 47(4):979-82. PubMed ID: 3802103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.